David Apelian
2016 - Achillion Pharmaceuticals
In 2016, David Apelian earned a total compensation of $1.3M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals, a 84% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $140,060 |
|---|---|
| Option Awards | $635,350 |
| Salary | $485,500 |
| Other | $32,652 |
| Total | $1,293,562 |
Apelian received $635.4K in option awards, accounting for 49% of the total pay in 2016.
Apelian also received $140.1K in non-equity incentive plan, $485.5K in salary and $32.7K in other compensation.
Rankings
In 2016, David Apelian's compensation ranked 6,989th out of 14,075 executives tracked by ExecPay. In other words, Apelian earned more than 50.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,989 out of 14,075 | 50th |
Division Manufacturing | 2,623 out of 5,488 | 52nd |
Major group Chemicals And Allied Products | 856 out of 1,900 | 55th |
Industry group Drugs | 658 out of 1,543 | 57th |
Industry Pharmaceutical Preparations | 522 out of 1,173 | 56th |
Source: SEC filing on April 17, 2017.
Apelian's colleagues
We found four more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2016.
2016
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2016
Joel Barrish
Achillion Pharmaceuticals
Chief Scientific Officer
2016
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2016
Mary Fenton
Achillion Pharmaceuticals